알라딘

헤더배너

베스트셀러: 최근 일주일간 가장 많이 판매된 도서입니다.

검색 rss

1.  
 
Pharmacokinetics and Metabolism in Drug Design (Hardcover, 3, Revised)
Douglas A. Smith | John Wiley & Sons Inc
228,950원(18% 할인 / 11,450원)
2.  
 
Croatia Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: Croatia Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
3.  
 
Costa Rica Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: Costa Rica Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
4.  
 
Colombia Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: Colombia Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

5.  
 
China Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: China Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
6.  
 
Chile Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: Chile Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
7.  
 
Gene Sculpting: Reshaping Life's Blueprint: Advanced gene editing for personalized medicine, gene therapy's clinical applications and challenges in ad (Paperback)
Chadwick Everett | Chadwick Everett
45,490원(18% 할인 / 2,280원)
8.  
 
Biomedical Engineering's Biometric Breakthroughs: Developing revolutionary medical devices (Paperback)
Jillian Fairweather | Jillian Fairweather
45,490원(18% 할인 / 2,280원)

9.  
 
Veterinary Antiparasitic Warfare: Strategies For Effective Parasite Control In Companion Animals (Paperback)
Genevieve Riversong | Genevieve Riversong
45,490원(18% 할인 / 2,280원)
10.  
 
Cancer's Cellular Combat: A guide to understanding cancer's biology, treatments, and impact on everyday life (Paperback)
Elias Langford | Elias Langford
45,490원(18% 할인 / 2,280원)
11.  
 
Brazil Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: Brazil Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
12.  
 
Argentina Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: Argentina Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

13.  
 
United States of America Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: United States of America Generic Launch Opportunit (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
14.  
 
Australia Key Drug Patent Expirations and Loss of Exclusivity (LOE) Dates 2025-2029: Australia Generic Launch Opportunity Dates 2025-2029 (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
15.  
 
Tecfidera (Dimethyl fumarate): A Fumarate Pioneer in Oral MS Treatment (Paperback)
Emily Hanover | Independently Published
22,730원(18% 할인 / 1,140원)
16.  
 
Vumerity (Diroximel fumarate): A Gentler Fumarate for MS (Paperback)
Emily Hanover | Independently Published
22,730원(18% 할인 / 1,140원)

17.  
 
Zeposia (Ozanimod): A Selective S1P Receptor Modulator for MS (Paperback)
Emily Hanover | Independently Published
22,730원(18% 할인 / 1,140원)
18.  
 
Narcan: A Lifesaving Guide to Understanding, Using, and Advocating for Naloxone (Paperback)
Jade Matthews | Independently Published
27,130원(18% 할인 / 1,360원)
19.  
 
Feline Pharmacology's Fundamentals: Dosages And Adverse Events In Cats (Paperback)
Xavier Beaumont | Xavier Beaumont
45,490원(18% 할인 / 2,280원)
20.  
 
Pain's Phantom: Deconstructing Suffering and Constructing Relief Through Pharmacology and Mindful Practices (Paperback)
Bethany Ashworth | Bethany Ashworth
45,490원(18% 할인 / 2,280원)

21.  
 
Tascenso ODT (Fingolimod): The Orally Disintegrating Tablet for MS (Paperback)
Emily Hanover | Independently Published
22,730원(18% 할인 / 1,140원)
22.  
 
Ponvory (Ponesimod): A Next-Gen S1P Receptor Modulator (Paperback)
Emily Hanover | Independently Published
22,730원(18% 할인 / 1,140원)
23.  
 
Maenclad (Mavenclad / Cladribine): Short-Course Oral MS Therapy (Paperback)
Emily Hanover | Independently Published
22,730원(18% 할인 / 1,140원)
24.  
 
Malware's Malevolent Matrix: Deciphering the complex algorithms that drive destructive malware (Paperback)
Hadley Kingsley | Hadley Kingsley
45,490원(18% 할인 / 2,280원)

25.  
 
Ethno botanical Explorations: Uncovering Traditional Medicine's Enduring Impact On Global Health (Paperback)
Naomi Oneal | Naomi Oneal
51,560원(18% 할인 / 2,580원)
26.  
 
Tramadol and Pain Management: Understanding Its Benefits, Risks, and Safe Use (Paperback)
Franklin Higgins | Independently Published
15,170원(18% 할인 / 760원)
27.  
 
Sildenafil for Men 100mg (Paperback)
Nirmit Nirav | Notion Press
16,670원(18% 할인 / 840원)
28.  
 
ZTALMY (ganaxolone) Drug Profile, 2025: ZTALMY (ganaxolone) drug patents, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

29.  
 
ZERBAXA (ceftolozane sulfate; tazobactam sodium) Drug Profile, 2025: ZERBAXA (ceftolozane sulfate; tazobactam sodium) drug patents, SPCs, clinical tri (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
30.  
 
ZEPZELCA (lurbinectedin) Drug Profile, 2025: ZEPZELCA (lurbinectedin) drug patents, clinical trials, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
31.  
 
ZEPOSIA (ozanimod hydrochloride) Drug Profile, 2025: ZEPOSIA (ozanimod hydrochloride) drug patents, SPCs, clinical trials, drug prices, suppliers, API (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
32.  
 
ZEMDRI (plazomicin sulfate) Drug Profile, 2025: ZEMDRI (plazomicin sulfate) drug patents, litigation, clinical trials, drug prices, suppliers, API sou (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

33.  
 
ZELSUVMI (berdazimer sodium) Drug Profile, 2025: ZELSUVMI (berdazimer sodium) drug patents (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
34.  
 
YUPELRI (revefenacin) Drug Profile, 2025: YUPELRI (revefenacin) drug patents, litigation, clinical trials, drug prices, drug prices, suppliers, API so (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
35.  
 
ZEJULA (niraparib tosylate) Drug Profile, 2025: ZEJULA (niraparib tosylate) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, A (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
36.  
 
XYWAV (calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate) Drug Profile, 2025: XYWAV (calcium oxybate; magnesium oxybate; potassium (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

37.  
 
XTAMPZA ER (oxycodone) Drug Profile, 2025: XTAMPZA ER (oxycodone) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
38.  
 
XPOVIO (selinexor) Drug Profile, 2025: XPOVIO (selinexor) drug patents, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
39.  
 
XOPENEX HFA (levalbuterol tartrate) Drug Profile, 2025: XOPENEX HFA (levalbuterol tartrate) drug patents, litigation, clinical trials, drug prices, an (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
40.  
 
XIGDUO XR (dapagliflozin; metformin hydrochloride) Drug Profile, 2025: XIGDUO XR (dapagliflozin; metformin hydrochloride) drug patents, patent challen (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

41.  
 
XIFAXAN (rifaximin) Drug Profile, 2025: XIFAXAN (rifaximin) drug patents, patent challenges, litigation, clinical trials, drug prices, annual drug sam (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
42.  
 
XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, A (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
43.  
 
XELSTRYM (dextroamphetamine) Drug Profile, 2025: XELSTRYM (dextroamphetamine) drug patents, litigation, drug prices, drug prices, suppliers, API sourc (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
44.  
 
XCOPRI (cenobamate) Drug Profile, 2025: XCOPRI (cenobamate) drug patents, SPCs, clinical trials, drug prices, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

45.  
 
WAKIX (pitolisant hydrochloride) Drug Profile, 2025: WAKIX (pitolisant hydrochloride) drug patents, litigation, SPCs, drug prices, suppliers, API sour (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
46.  
 
UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
47.  
 
TYMLOS (abaloparatide) Drug Profile, 2025: TYMLOS (abaloparatide) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
48.  
 
TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical trials, drug prices, suppliers, API s (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)

49.  
 
TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) drug (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)
50.  
 
TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: drug patents, patent challenges, litigation, PTAB cases, SPCs, clinica (Paperback)
Drugpatentwatch | Independently Published
379,250원(18% 할인 / 18,970원)